Samsung Biologics
Samsung Biologics is a South Korean biotechnology company headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, it provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry.
| Company type | Public |
|---|---|
| KRX: 207940 | |
| Industry | Biopharmaceuticals |
| Founded | 2011 |
| Headquarters | , |
Area served | Worldwide |
Key people | John Rim, President and CEO |
| Owners |
|
| Subsidiaries | Samsung Bioepis |
| Korean name | |
| Hangul | |
| Revised Romanization | Samseong Baiorojikseu |
| McCune–Reischauer | Samsŏng Paiorojiksŭ |
| Website | www |
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly and AstraZeneca. Samsung Biologics also partnered with Moderna for fill-finish, packaging and labeling of its mRNA vaccine, Spikevax, during the COVID-19 pandemic.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.